Memphis Pharmaceuticals turns to profits in unaudited annual results

Updated 7/14/2016 11:56:47 AM

Arab Finance: Memphis Pharmaceuticals (MPCI) Board of Directors was held on 13/07/2016.

BoD approved unaudited financial results for the fiscal period from July2015 till June 2016, which revealed posting net profits of LE452 thousand against incurring net losses of LE10.304 million a year earlier.

Source: EGX & Arab Finance editor